1Mercadante S,Ripamonti C,Casuccio A,et al.Comparison of octreotide and hyoscine butylbromide in controlling gastrointestinal symptoms due to malignant inoperable bowel obstruction[J].Support Care Cancer,2000,8(3):188-191.
2Pandha HS,Waxman J.Octreotide in malignant intestinal obstruction[J].Anticancer Drugs,1996,7(1):5-10.
3Wright HK,Orieu JJ,Tilson MD.Water absorption in experimental closed segment obstruction of ileum in man[J].Am J Surg,1971,121 (1):96-99.
4Randall TC,Rubin SC.Management of intestinal obstruction in the patient with ovarian cancer[J].Oncology,2000,14 (8):1159-1163.
5Mystakidou K,Tsilika E,Kalaidopoulou O,et al.Comparison of octreotide administration vs conservative treatment in the management of inoperable bowel obstruction in patients with far advanced cancer[J].Anticancer Res,2002,22 (2 B):1187 -1192.
7Ripamonti C,Twycross R,Baines M,et al.Clinical-practice recommendations for the management of bowel obstruction in patients with end-stage cancer[J].Support Care Cancer,2001,9(4):223-233.
8de Herder WW,Lamberts SW.Somatostatin and somatostatin analogues:diagnostic and therapeutic uses[J].Curr Opin Oncol,2002,14(1):53-57.
9Lamberts SW,de Herder WW,Hofland LJ.Somatostatin analogs in the diagnosis and treatment of cancer[J].Trends Endocrinol Metab,2002,13(10):451-457.
3Kato M, Kaise M, Obata T, et al. Bacteremia and endotoxemia af- ter endoscopic submucosal dissection for gastric neoplasia: pilot study[ J]. Gastric Cancer,2012,15 ( 1 ) : 15-20.
4Andrea Silver,Philip Bendick,Harry Wasvary.Safety and efficacy of superselective angioembolization in control of lower gastrointestinal hemorrhage[J].The American Journal of Surgery.2005(3)
